Skip to main content
. 2022 Mar 1;13:852215. doi: 10.3389/fimmu.2022.852215

Table 2.

The most commonly used drugs in monotherapy and combination therapy for anit-IgLON5 disease.

Monotherapy corticosteroids i.v.
IVIg
plasmapheresis
rituximab
Combination therapy IVIg + corticosteroids
IVIg + plasmapheresis
corticosteroids + azathioprine
IVIg + mycophenolate mofetil
IVIg + cyclophosphamide
IVIg + plasmapheresis + rituximab – recommended

The bold values were implemented to highlight the authors' recommendations considering treatment.